The aim was to analyse the tumor expression of Notch1, Hes1, Ascl1, and DLL3in Small-Cell Lung Cancer (SCLC) and each such biomarker’s potentialassociation with clinical characteristics and prognosis afterplatinum-doublet chemotherapy (PDCT). This evidence concerns the gene HES1 and neoplasm.